ATE242784T1 - Mit der familie der hämolysin-toxine verwandte antigene eisen-ubnterdrückende proteine des n. meningitis - Google Patents

Mit der familie der hämolysin-toxine verwandte antigene eisen-ubnterdrückende proteine des n. meningitis

Info

Publication number
ATE242784T1
ATE242784T1 AT91913698T AT91913698T ATE242784T1 AT E242784 T1 ATE242784 T1 AT E242784T1 AT 91913698 T AT91913698 T AT 91913698T AT 91913698 T AT91913698 T AT 91913698T AT E242784 T1 ATE242784 T1 AT E242784T1
Authority
AT
Austria
Prior art keywords
ubn
meningitis
antigen
iron
toxin family
Prior art date
Application number
AT91913698T
Other languages
English (en)
Inventor
P Frederick Sparling
Stuart Alan Thompson
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE242784T1 publication Critical patent/ATE242784T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT91913698T 1990-07-16 1991-07-16 Mit der familie der hämolysin-toxine verwandte antigene eisen-ubnterdrückende proteine des n. meningitis ATE242784T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55264990A 1990-07-16 1990-07-16
PCT/US1991/005014 WO1992001460A1 (en) 1990-07-16 1991-07-16 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins

Publications (1)

Publication Number Publication Date
ATE242784T1 true ATE242784T1 (de) 2003-06-15

Family

ID=24206214

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91913698T ATE242784T1 (de) 1990-07-16 1991-07-16 Mit der familie der hämolysin-toxine verwandte antigene eisen-ubnterdrückende proteine des n. meningitis

Country Status (9)

Country Link
EP (2) EP0539492B1 (de)
JP (2) JP3329452B2 (de)
AT (1) ATE242784T1 (de)
AU (1) AU8298991A (de)
CA (1) CA2087160A1 (de)
DE (1) DE69133276T2 (de)
DK (1) DK0539492T3 (de)
ES (1) ES2202297T3 (de)
WO (1) WO1992001460A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
EP1137777B1 (de) * 1998-12-08 2011-10-05 GlaxoSmithKline Biologicals s.a. Neue verbindungen abgeleitet von neisseria meningitidis
EP1144643A1 (de) 1999-01-15 2001-10-17 SMITHKLINE BEECHAM BIOLOGICALS s.a. Neisseria meningitidis antigen
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
DE20321889U1 (de) 2002-08-02 2012-03-12 Glaxosmithkline Biologicals S.A. Impfstoffzusammensetzung
DK1556477T3 (en) 2002-11-01 2017-10-23 Glaxosmithkline Biologicals Sa Process for drying
ATE474595T1 (de) 2003-10-02 2010-08-15 Glaxosmithkline Biolog Sa B. pertussis antigene und ihre verwendung bei der vakzinierung
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
EP2032161B1 (de) 2006-06-12 2012-07-11 GlaxoSmithKline Biologicals S.A. L3v los impfstoffe
JP2013521326A (ja) 2010-03-10 2013-06-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine

Also Published As

Publication number Publication date
AU8298991A (en) 1992-02-18
WO1992001460A1 (en) 1992-02-06
CA2087160A1 (en) 1992-01-17
EP0539492A1 (de) 1993-05-05
EP1338607A2 (de) 2003-08-27
EP1338607A3 (de) 2004-08-18
EP0539492A4 (en) 1993-09-01
DE69133276T2 (de) 2003-11-27
ES2202297T3 (es) 2004-04-01
DE69133276D1 (de) 2003-07-17
DK0539492T3 (da) 2003-09-22
EP0539492B1 (de) 2003-06-11
JP3329452B2 (ja) 2002-09-30
JPH06502394A (ja) 1994-03-17
JP2002233390A (ja) 2002-08-20

Similar Documents

Publication Publication Date Title
ATE157397T1 (de) Lebende vakzine
Forsgren et al. The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin
ATE242784T1 (de) Mit der familie der hämolysin-toxine verwandte antigene eisen-ubnterdrückende proteine des n. meningitis
ATE127345T1 (de) Stressproteine und verwendungen dafür.
DK0561907T3 (da) Proteiner med ændrede epitoper og fremgangsmåder til fremstilling deraf
ATE120093T1 (de) Meningococcales klasse i-aussenmembranprotein- vakzin.
KR890701125A (ko) 무병원성 미생물 및 이의 용도
ATE180280T1 (de) Expression rekombinanter proteine in attenuierten bakterien
AP2001002199A0 (en) Novel streptococcus antigens
DK0498851T3 (da) Tumorassocieret urinantigen, anvendelse af antigene underenheder og fremgangsmåder til detektion
Purven et al. Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody
EP0303983A3 (en) Synthetic peptides, antibodies directed against them and their use
DE3851492D1 (de) Ein gattungsspezifisches Listeria-Antigen, identifiziert durch monoklonale Antikörper.
FI854839L (fi) Vaccin eller diagnostisk produkt erhaollen fraon peptid, samt daeri anvaendbar polypeptid.
Anwar et al. Neutralisation of biological activities of pertussis toxin with a monoclonal antibody
EP0585364A4 (de) Das durch den monoklonalen menschlichen antikörper 81av78 erkannte antigen ctaa 81av78.
Beernink et al. Proteins adhering to Escherichia coli after exposure to guinea-pig serum
Greene et al. An improved chromatographic method for the separation of egg yolk IgG into subpopulations utilizing immobilized metal ion (Fe3+) affinity chromatography
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
DK0570682T3 (da) Syntetiske lipid-A-glycoconjugat-antigener til anvendelse i vacciner
DE69019092D1 (de) Von Babesia abgeleitete Antigene und Polypeptide (12D3-Antigen).
Gorlina et al. Immunochemical properties of a protective cross-reacting antigen of meningococci

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0539492

Country of ref document: EP

EELA Cancelled due to lapse of time